Canadian Cancer Society: Innovation & Innovation to Impact Grants

Canadian Cancer Society: Innovation & Innovation to Impact Grants

Edward Chow

Innovation Grant

Sunnybrook Health Sciences Centre

Department of Radiation Oncology

Handheld ultrasound-guided focused ultrasound for palliation of bone metastases: A pilot study

   200,000

Daniel De Carvalho

Innovation Grant

UHN - Ontario Cancer Institute/PMH

Department of Medical Biophysics

BAZ2 bromodomain as a novel target for colorectal cancer treatment

   200,000

Eleftherios Diamandis

Innovation Grant

Mount Sinai Hospital

Department of Laboratory Medicine & Pathobiology

Diagnosis of prostate cancer with genomic biomarkers measured in seminal plasma

   200,000

Peter Dirks

Innovation Grant

Hospital for Sick Children

Department of Surgery

Pharmacologic and optogenetic dopamine-directed therapy of glioblastoma stem cells

   198,516

Daniel Durocher

Innovation Grant

Mount Sinai Hospital

Department of Molecular Genetics

Understanding PARP inhibitor sensitivity and resistance

   200,000

Housheng He

Innovation Grant

UHN - Ontario Cancer Institute/PMH

Department of Medical Biophysics

Identifying long non-coding RNAs associated with prostate cancer predisposition and progression

   200,000

Michael Hoffman

Innovation Grant

UHN - Ontario Cancer Institute/PMH

Department of Medical Biophysics

Epigenetic DNA modifications as drivers of leukemia gene expression programs

   200,000

Thomas Kislinger

Innovation Grant

UHN - Ontario Cancer Institute/PMH

Department of Medical Biophysics

Exosomal cargo to identify targets within the tumour microenvironment

   193,900

Fei-Fei Liu

Innovation Grant

UHN - Ontario Cancer Institute/PMH

Department of Radiation Oncology

Epigenetic reprogramming of radiation fibrosis using adipose-derived stromal cells

   200,000

Naomi Matsuura

Innovation Grant

Campus

Department of Medical Imaging

MRI-guided local release of drugs that target tumour metabolism with confirmation using hyperpolarized [1-13C]pyruvate MRI

   200,000

Brian Raught

Innovation Grant

UHN - Ontario Cancer Institute/PMH

Department of Medical Biophysics

Arsenic trioxide therapy for non-acute promyelocytic leukemia (APL) acute myelogenous leukemia (AML)

   199,600

Anna Sawka

Innovation Grant

UHN - Toronto Western Hospital

Department of Medicine

A novel active surveillance approach to primary management of low-risk papillary thyroid cancer

     92,560

Rama Khokha

Innovation to Impact Grant

UHN - Ontario Cancer Institute/PMH

Department of Laboratory Medicine & Pathobiology

Novel genetic targets in breast cancer subtypes via Lentihop mutagenesis

   450,000

Igor Stagljar

Innovation to Impact Grant

Campus

Department of Biochemistry

Functional analysis of the EGFR interactome and its role in non-small cell lung cancer

   450,000

Back to Top